PIK3CA and ovarian cancer: 94 % of samples without Chr3(q26.2) Amp had PIK3CA mutations, whereas PIK3CA Amp were predominantly carried by ovarian cancer harboring Chr3(q26.2) Amp (P < 0.001; Fig. S6E).